References

Multi‐omics reveal the dysregulated gut‐joint axis in knee synovitis: Data from two osteoarthritis studies in China

10.1002/advs.202512020 · ExternalCitation · doi-reference

Plasma proteomics identifies thousand-and-one-amino acid kinase 3 as a potential biomarker of rheumatoid arthritis activity and a novel therapeutic target

10.1002/art.70020 · ExternalCitation · doi-reference

Role of liquid biopsies in rheumatoid arthritis

10.1007/978-1-0716-3346-5_16 · ExternalCitation · doi-reference

Complement factor H attenuates TNF-α-induced inflammation by upregulating EIF3C in rheumatoid arthritis

10.1007/978-981-97-7640-5_110 · ExternalCitation · doi-reference

Genetics of rheumatoid arthritis

10.1007/s00281-022-00912-0 · ExternalCitation · doi-reference

Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis

10.1007/s00296-017-3732-3 · ExternalCitation · doi-reference

ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography

10.1007/s00296-019-04492-5 · ExternalCitation · doi-reference

Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology

10.1007/s10067-010-1596-y · ExternalCitation · doi-reference

Predictive, personalized, preventive and participatory (4P) medicine applied to telemedicine and eHealth in the literature

10.1007/s10916-019-1279-4 · ExternalCitation · doi-reference

Therapeutic options and cost-effectiveness for rheumatoid arthritis treatment

10.1007/s11926-020-00921-8 · ExternalCitation · doi-reference

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD): Update on prevalence, risk factors, pathogenesis, and therapy

10.1007/s11926-024-01155-8 · ExternalCitation · doi-reference

Treatment of persons with rheumatoid arthritis with a history of cancer

10.1007/s11926-025-01200-0 · ExternalCitation · doi-reference

Polymorphisms in STAT4 and PTPRC genes in rheumatoid arthritis: a Brazilian study and meta-analysis of susceptibility and TNFi response

10.1007/s12026-025-09719-1 · ExternalCitation · doi-reference

Machine learning and feature selection for drug response prediction in precision oncology applications

10.1007/s12551-018-0446-z · ExternalCitation · doi-reference

Effective second-line b/tsDMARDs for patients with rheumatoid arthritis unresponsive to first-line b/tsDMARDs from the FIRST Registry

10.1007/s40744-025-00747-9 · ExternalCitation · doi-reference

Spatiotemporal distributions and regional disparities of rheumatoid arthritis in 953 global to local locations, 1980-2040, with deep learning-empowered forecasts and evaluation of interventional policies' benefits

10.1016/j.ard.2025.04.009 · ExternalCitation · doi-reference

METTL1-mediated internal m7G methylation of cathepsin B mRNA promotes synovial aggression in rheumatoid arthritis

10.1016/j.ard.2025.09.010 · ExternalCitation · doi-reference

Precision medicine in rheumatoid arthritis

10.1016/j.berh.2022.101742 · ExternalCitation · doi-reference

Artificial intelligence for proteomics and biomarker discovery

10.1016/j.cels.2021.06.006 · ExternalCitation · doi-reference

Systems immunology meets clinical translation: Multi-omic approaches to predict therapy response in cancer and autoimmune disease

10.1016/j.clicom.2025.12.002 · ExternalCitation · doi-reference

New learnings from the molecular pathology of the synovial tissue in rheumatoid arthritis: from pathogenesis to therapeutic targeting toward precision medicine

10.1016/j.coi.2026.102785 · ExternalCitation · doi-reference

Integration strategies of multi-omics data for machine learning analysis

10.1016/j.csbj.2021.06.030 · ExternalCitation · doi-reference

ACPA-negative rheumatoid arthritis: From immune mechanisms to clinical translation

10.1016/j.ebiom.2022.104233 · ExternalCitation · doi-reference

Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review

10.1016/j.ejmech.2018.09.027 · ExternalCitation · doi-reference

ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis

10.1016/j.imlet.2019.08.009 · ExternalCitation · doi-reference

Conceptual innovation: 4P medicine and 4P surgery

10.1016/j.jviscsurg.2021.01.003 · ExternalCitation · doi-reference

Rheumatoid arthritis: Early diagnosis and treatment

10.1016/j.mcna.2020.10.006 · ExternalCitation · doi-reference

Predicting best treatment in rheumatoid arthritis

10.1016/j.semarthrit.2023.152329 · ExternalCitation · doi-reference

Personalised treatment of rheumatoid arthritis based on cytokine profiles and synovial tissue signatures: potentials and challenges

10.1016/j.semarthrit.2025.152740 · ExternalCitation · doi-reference

Liquid biopsies to guide therapeutic decisions in rheumatoid arthritis

10.1016/j.trsl.2018.07.004 · ExternalCitation · doi-reference

Mesothelin as a biomarker and potential therapeutic target in rheumatoid arthritis bone destruction

10.1016/j.xcrm.2025.102430 · ExternalCitation · doi-reference

Magnetic resonance imaging RAMRIS-SAFE score-A low-risk effective measure of rapid response to therapy in rheumatoid arthritis clinical trials

10.1016/s0950-3579(96)80057-4 · ExternalCitation · doi-reference

Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

10.1016/s2665-9913(23)00211-4 · ExternalCitation · doi-reference

STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway

10.1038/s41392-022-01050-7 · ExternalCitation · doi-reference

Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission

10.1038/s41467-018-05044-4 · ExternalCitation · doi-reference

MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification

10.1038/s41467-021-23774-w · ExternalCitation · doi-reference

Clonal associations between lymphocyte subsets and functional states in rheumatoid arthritis synovium

10.1038/s41467-024-49186-0 · ExternalCitation · doi-reference

Deep MALDI-MS spatial omics guided by quantum cascade laser mid-infrared imaging microscopy

10.1038/s41467-025-59839-3 · ExternalCitation · doi-reference

Microvascular endothelial dysfunction in rheumatoid arthritis

10.1038/s41584-018-0022-8 · ExternalCitation · doi-reference

Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes

10.1038/s41584-020-0413-5 · ExternalCitation · doi-reference

Matrix metalloproteinases in arthritis: towards precision medicine

10.1038/s41584-023-00966-w · ExternalCitation · doi-reference

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

10.1038/s41591-022-01789-0 · ExternalCitation · doi-reference

Biomarkers for the diagnosis and treatment of rheumatoid arthritis - a systematic review

10.1080/00325481.2022.2052626 · ExternalCitation · doi-reference

Targeting methionine cycle as a potential therapeutic strategy for immune disorders

10.1080/14728222.2017.1370454 · ExternalCitation · doi-reference

RABC: Rheumatoid arthritis bioinformatics center

10.1093/nar/gkac850 · ExternalCitation · doi-reference

Classical hand and foot deformities in rheumatoid arthritis

10.1093/qjmed/hcab316 · ExternalCitation · doi-reference

Patient experiences of physical activity and exercise in rheumatoid arthritis

10.1093/rap/rkac098 · ExternalCitation · doi-reference

Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease

10.1093/rheumatology/keaa860 · ExternalCitation · doi-reference

Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs

10.1093/rheumatology/keab609 · ExternalCitation · doi-reference

Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability

10.1093/rheumatology/kev421 · ExternalCitation · doi-reference

Epigenetics in rheumatoid arthritis

10.1097/bor.0000000000000128 · ExternalCitation · doi-reference

Monitoring rheumatoid arthritis

10.1097/bor.0b013e328345743a · ExternalCitation · doi-reference

Periodontal disease: A systemic condition

10.1111/prd.12616 · ExternalCitation · doi-reference

Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study

10.1136/annrheumdis-2011-200963 · ExternalCitation · doi-reference

DNA methylome signature in rheumatoid arthritis

10.1136/annrheumdis-2012-201526 · ExternalCitation · doi-reference

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

10.1136/ard-2022-223356 · ExternalCitation · doi-reference

Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications

10.1136/bmj.k1036 · ExternalCitation · doi-reference

Differences in avidity of anti-post-translationally modified protein antibodies in mouse models and rheumatoid arthritis patients: not one-size-fits-all

10.1136/rmdopen-2024-004131 · ExternalCitation · doi-reference

Analyzation of the peripheral blood mononuclear cells atlas and cell communication of rheumatoid arthritis patients based on single-cell RNA-Seq

10.1155/2023/6300633 · ExternalCitation · doi-reference

Multi-omics data integration, interpretation, and its application

10.1177/1177932219899051 · ExternalCitation · doi-reference

Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management

10.1183/16000617.0011-2021 · ExternalCitation · doi-reference

Translational precision medicine: an industry perspective

10.1186/s12967-021-02910-6 · ExternalCitation · doi-reference

Potential mechanisms of acupuncture treatment for rheumatoid arthritis: a study based on network topology and machine learning

10.1186/s13020-025-01209-8 · ExternalCitation · doi-reference

Serum tryptophan-kynurenine metabolites served as biomarkers of disease activity in rheumatoid arthritis and linked to immune imbalance

10.1186/s13075-025-03596-7 · ExternalCitation · doi-reference

Rheumatoid arthritis and oxidative stress

10.14715/cmb/2022.68.6.28 · ExternalCitation · doi-reference

Early aggressive treatment with DMARDs vs. step-up therapy in rheumatoid arthritis: a traditional review of joint damage and functional outcomes

10.1515/jbcpp-2025-0060 · ExternalCitation · doi-reference

Optimizing the expediency of TNFi in rheumatoid arthritis: offering a TNFi holiday in patients having reached low-disease activity in the maintenance phase

10.1517/14712598.2014.955009 · ExternalCitation · doi-reference

Diagnostic performance of the multi-biomarker disease activity (MBDA) score for rheumatoid arthritis in patients with new-onset joint symptoms: An age-stratified retrospective study

10.2147/oarrr.s576941 · ExternalCitation · doi-reference

Potential role of bioactive lipids in rheumatoid arthritis

10.2174/1381612827666210525164734 · ExternalCitation · doi-reference

Assessment of disease activity in rheumatoid arthritis by multi-biomarker disease activity (MBDA) score

10.2177/jsci.39.37 · ExternalCitation · doi-reference

Effectiveness of composite Ayurveda regimen in a black box design for the management of rheumatoid arthritis: Protocol of a single arm, community-based study

10.2196/57918 · ExternalCitation · doi-reference

The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs

10.2217/pme-2018-0001 · ExternalCitation · doi-reference

Rheumatoid arthritis: a review of the key clinical features and ongoing challenges of the disease

10.23736/s0031-0808.24.05272-8 · ExternalCitation · doi-reference

Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation

10.3310/hta25080 · ExternalCitation · doi-reference

MoGCN: A multi-omics integration method based on graph convolutional network for cancer subtype analysis

10.3389/fgene.2022.806842 · ExternalCitation · doi-reference

Effector functions of CD4+ T cells at the site of local autoimmune inflammation—lessons from rheumatoid arthritis

10.3389/fimmu.2019.00353 · ExternalCitation · doi-reference

Autoantibodies in rheumatoid arthritis – laboratory and clinical perspectives

10.3389/fimmu.2021.685312 · ExternalCitation · doi-reference

Metabolomics in rheumatoid arthritis: Advances and review

10.3389/fimmu.2022.961708 · ExternalCitation · doi-reference

Lipid metabolism and rheumatoid arthritis

10.3389/fimmu.2023.1190607 · ExternalCitation · doi-reference

An overview of multi-omics technologies in rheumatoid arthritis: applications in biomarker and pathway discovery

10.3389/fimmu.2024.1381272 · ExternalCitation · doi-reference

Macrophage polarization in rheumatoid arthritis: signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts

10.3389/fimmu.2024.1394108 · ExternalCitation · doi-reference

Advancing precision rheumatology: applications of machine learning for rheumatoid arthritis management

10.3389/fimmu.2024.1409555 · ExternalCitation · doi-reference

Integrated multi-omics for potential biomarkers and molecular mechanism of persistent inflammatory refractory rheumatoid arthritis

10.3389/fimmu.2025.1574783 · ExternalCitation · doi-reference

Editorial: Revolutionizing immunological disease understanding through single cell multi-omics technologies

10.3389/fimmu.2025.1628120 · ExternalCitation · doi-reference

Integrated multi-omics analyses in oncology: A review of machine learning methods and tools

10.3389/fonc.2020.01030 · ExternalCitation · doi-reference

Gastrodin attenuates rheumatoid arthritis by targeting KAT8 to inhibit the lactylation of H3K9

10.3389/fphar.2025.1559744 · ExternalCitation · doi-reference

Recent advances in understanding the pathogenesis of rheumatoid arthritis: New treatment strategies

10.3390/cells10113017 · ExternalCitation · doi-reference

Current understanding of an emerging role of HLA-DRB1 gene in rheumatoid arthritis–from research to clinical practice

10.3390/cells9051127 · ExternalCitation · doi-reference

Interleukin-6 in rheumatoid arthritis

10.3390/ijms21155238 · ExternalCitation · doi-reference

Spatial omics in clinical research: A comprehensive review of technologies and guidelines for applications

10.3390/ijms26093949 · ExternalCitation · doi-reference

Beyond joints: Neuropsychiatric benefits of TNF-α and IL-6 inhibitors in rheumatoid arthritis—narrative review

10.3390/ijms26178361 · ExternalCitation · doi-reference

Janus kinase inhibitors in rheumatoid arthritis: An update on the efficacy and safety of tofacitinib, baricitinib and upadacitinib

10.3390/jcm12206690 · ExternalCitation · doi-reference

Excavatolide B attenuates rheumatoid arthritis through the inhibition of osteoclastogenesis

10.3390/md15010009 · ExternalCitation · doi-reference

Rheumatoid arthritis: The continuum of disease and strategies for prediction, early intervention, and prevention

10.3899/jrheum.2023-0334 · ExternalCitation · doi-reference

The genetics of rheumatoid arthritis

10.7748/ns.9.12.33.s33 · ExternalCitation · doi-reference